Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Estrogen Receptor
100%
Androgens
100%
Prostate Cancer Cells
100%
Selective Modulation
100%
Genistein
66%
Antiproliferative Activity
50%
PC-3
50%
Phenyl
33%
Receptor Targets
33%
FasL
33%
Quantitative PCR
16%
ICI 182,780
16%
Estrogen Receptor Agonists
16%
AKT1
16%
Immunoblotting
16%
Small Interfering RNA (siRNA)
16%
Specific Activity
16%
Estradiol
16%
Low Incidence
16%
Estrogen Receptor Gene
16%
Prostate Cancer
16%
Apoptosis
16%
Akt Phosphorylation
16%
MRNA Expression
16%
Decreased Expression
16%
ERK1
16%
Hormone-sensitive Prostate Cancer
16%
Reporter Assay
16%
ERK Phosphorylation
16%
TUNEL
16%
Phytoestrogens
16%
2H-1
16%
Subtype-specific
16%
Human Prostate Cancer Cells
16%
Caspase-3 Activity
16%
Lead Structure
16%
Annexin V
16%
Dietary Consumption
16%
Multi-pathway
16%
PC-3 Cells
16%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Prostate Cancer
100%
Androgen
100%
Benzopyran Derivative
100%
Genistein
50%
Selective Estrogen Receptor Modulator
37%
Antiproliferative Activity
25%
Receptor Agonist
12%
Tamoxifen
12%
Protein Kinase B
12%
Tumor Necrosis Factor
12%
Receptor Subtype
12%
Western Blot
12%
Small Interfering RNA
12%
Caspase 3
12%
Diethylstilbestrol
12%
Phytoestrogen
12%
Lipocortin 5
12%
Mitogen Activated Protein Kinase 3
12%
Messenger RNA
12%
Estrogen Receptor Antagonist
12%